MustGrow Biologics Corp., classified in the Chemicals sector, is a listed company. Its insiders report their share dealings to SEDI. The last twelve months, up to 22 October 2026, brought 1 filing signed by 1 insider.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
For context, the typical company on the same exchange (median of 2,472 companies) published 12 filings over the same period, against 1 filing here. The full history, which starts in 2018, counts 25 purchases against 1 sale.
No insider has bought MustGrow Biologics Corp. shares on the open market in the past twelve months.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 69 declarations
MustGrow Biologics Corp. is a Canadian company focused on developing biological solutions for agriculture. It emphasizes innovative products that promote sustainability and food safety.